NCT06783738View on ClinicalTrials.gov

Physical Activity in Acute Lymphoblastic Leukemia (ALL)

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

March 15, 2023

Study Completion Date

March 15, 2023

Conditions
Acute Leukemia
Interventions
OTHER

Exercise

The participants will come to our lab twice. In the first visit we will perform a fitness assessment, using a noninvasive, cardiopulmonary exercise testing used routinely to measure fitness in children.

All Listed Sponsors
lead

University of California, Irvine

OTHER

NCT06783738 - Physical Activity in Acute Lymphoblastic Leukemia (ALL) | Biotech Hunter | Biotech Hunter